SS
KLRA

SBI Securities’s Kailera Therapeutics KLRA Stock Holding History

SBI Securities’s Portfolio KLRA Stock Details KLRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22 Buy
+1
New +$22 ﹤0.01% 3833

Other funds holding KLRA

ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

SBI Securities's KLRA Position: Q2 2026 in Review

SBI Securities opened a new position in Kailera Therapeutics (KLRA) in Q2 2026: 1 share worth $22. The stake represents ﹤0.01% of the portfolio and ranks #3833 among its holdings.

6 funds tracked by Wall St. Rank hold KLRA as of Q2 2026.

  • SBI Securities held 1 share of Kailera Therapeutics worth $22 as of Q2 2026.
  • Kailera Therapeutics was a new SBI Securities position in Q2 2026.
  • Kailera Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3833 holding.
  • 6 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.